Internal Medicine, Nephrology · Poughkeepsie, NY
NPI
1184963746
Since 2013
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2585 South Rd, Suite 15a
Poughkeepsie, NY, 12601
Phone (845) 454-1399
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
11,552 services
Medicare patients, 2024
885
Average age 75
Drug cost, 2024
$7.2M
2,474 prescriptions
Company payments, 2025
$125K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Payam Shakouri was code 99233 (hospital e&m - subsequent), 914 times for 374 patients. In total Payam Shakouri billed 11,552 services in 36 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 914 | 374 | $106.31 | $97K |
| 99214 Office E&M - Established | Office | 341 | 194 | $63.05 | $22K |
| 90960 ESRD Related Services (not dialysis) | Office | 285 | 157 | $312.65 | $89K |
| 99232 Hospital E&M - Subsequent | Facility | 281 | 180 | $70.78 | $20K |
| 90937 Hemodialysis | Facility | 281 | 120 | $91.09 | $26K |
| 99223 Hospital E&M - Initial | Facility | 270 | 243 | $155.52 | $42K |
| 99213 Office E&M - Established | Office | 144 | 101 | $53.41 | $7,692 |
| 90935 Hemodialysis | Facility | 82 | 66 | $62.75 | $5,146 |
| 90961 ESRD Related Services (not dialysis) | Office | 81 | 70 | $262.09 | $21K |
| 90966 ESRD Related Services (not dialysis) | Office | 49 | 27 | $259.90 | $13K |
| 99222 Hospital E&M - Initial | Facility | 40 | 38 | $117.21 | $4,689 |
| 90947 Peritoneal Dialysis | Facility | 35 | 12 | $109.32 | $3,826 |
| 99204 Office E&M - New | Office | 29 | 29 | $139.97 | $4,059 |
| 90945 Peritoneal Dialysis | Facility | 22 | 17 | $77.01 | $1,694 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 19 | 17 | $109.61 | $2,083 |
By year: 2022 $668K for 3,736 services; 2023 $1.3M for 12,855 services; 2024 $1.4M for 11,552 services.
Medicare prescription drug claims, 2024
In 2024, the drug Payam Shakouri prescribed most often to Medicare patients was Kerendia (Finerenone), with 327 prescriptions and refills. In total Payam Shakouri wrote 2,474 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Kerendia Finerenone | 327 | 519 | 57 | $328K |
| Farxiga Dapagliflozin Propanediol | 209 | 342 | 49 | $190K |
| Furosemide Generic | 170 | 414 | 66 | $1,079 |
| Amlodipine Besylate Generic | 86 | 204 | 34 | $396 |
| Lokelma Sodium Zirconium Cyclosilicate | 75 | 85 | 22 | $60K |
| Allopurinol Generic | 70 | 192 | 27 | $616 |
| Ozempic Semaglutide | 61 | 83 | 17 | $74K |
| Cortrophin Corticotropin | 59 | 66 | 22 | $3.4M |
| Losartan Potassium Generic | 56 | 157 | 22 | $445 |
| Veltassa Patiromer Calcium Sorbitex | 55 | 63 | 16 | $59K |
| Mycophenolate Mofetil Generic | 54 | 106 | 20 | $5,112 |
| Lisinopril Generic | 51 | 135 | 18 | $350 |
| Krystexxa Pegloticase | 46 | 46 | 17 | $2.5M |
| Torsemide Generic | 46 | 102 | 14 | $1,500 |
| Tamsulosin Hcl Generic | 44 | 110 | 14 | $428 |
Brand drugs: - claims; generic drugs: 1,393 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Payam Shakouri $125K ($125K in general payments such as food, travel and fees) from 21 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $46K.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 60 | $46K |
| Amgen Inc. AMGN | 49 | $33K |
| Travere Therapeutics, Inc. TVTX | 26 | $19K |
| Aurinia Pharma U.S., Inc. AUPH | 24 | $15K |
| ANI Pharmaceuticals, Inc. ANIP | 19 | $11K |
| Mallinckrodt Hospital Products Inc. | 16 | $430 |
| Fresenius USA Marketing, Inc. | 7 | $168 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $157 |
| OPKO Pharmaceuticals, LLC | 14 | $154 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $144 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.